FDA Warns Industry: We’re Looking ‘Closely And More In-Depth At Class II Recalls’
Also: Troubles with production and process controls at the heart of most class II’s, agency analysis reveals
Executive Summary
The US FDA says it’s keeping a sharp eye on medical device manufacturers that initiate the moderate-risk recalls – especially firms that trigger multiple class II’s in a given year.